Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.

Revenue
+3.22%
EPS
+1,855.6%
Free cash flow
−6.48%
Total debt
−1.13%

Quarter to September 2026, against a year earlier

24.98 2.21 −8.13%
Market cap
$4.0B
P/E
6.4×
Fwd P/E
21.5×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a

Envista Holdings Corporation (NVST) Free cash flow

Alert me on Free cash flow

Envista Holdings Corporation's free cash flow for fiscal 2025 was $230.9M, down 23.7% from $302.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $244.6M. Over the past ten years it has ranged from $110.3M (fiscal 2022) to $417.0M (fiscal 2016); the current reading is higher than 30% of that period. Envista Holdings Corporation ranks 15th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $230.9M (23.75%)
FY2024 $302.8M 35.42%
FY2023 $223.6M 102.72%
FY2022 $110.3M (65.37%)
FY2021 $318.5M 31.88%
FY2020 $241.5M (24.84%)
FY2019 $321.3M (2.01%)
FY2018 $327.9M 5.67%
FY2017 $310.3M (25.59%)
FY2016 $417.0M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $63.5M (39.58%)
Jun 2026 $105.1M —
Mar 2026 −$15.7M —
Dec 2025 $91.7M 35.05%
30 more quarters

Against its own ten years

Low $110.3M High $417.0M
Ten-year median $306.6M
Current reading's percentile 30

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on NVST